Drug intelligence / Profile preview

AquADEKs-2

Development stage
Unknown
Lead developer
University of Colorado Denver
Modality
Small Molecules
Administration
Oral
01

Overview

AquADEKs-2 is an investigational, antioxidant-enriched multivitamin supplement specifically formulated for patients with cystic fibrosis (CF) and pancreatic insufficiency. Developed in collaboration with the University of Colorado, Denver, it is a modified version of the original AquADEKs formulation. The supplement contains standard fat-soluble vitamins (A, D, E, and K) along with an enhanced profile of antioxidants, including beta-carotene, mixed tocopherols, coenzyme Q10 (CoQ10), and mixed carotenoids (lutein, lycopene, and zeaxanthin), as well as the minerals zinc and selenium. It is designed to address the systemic oxidative stress and chronic inflammation characteristic of CF. Clinical studies, such as the Phase 2 trial NCT01859390, have evaluated its ability to increase systemic antioxidant levels and potentially reduce pulmonary exacerbations, although it did not significantly reduce respiratory inflammation compared to standard CF multivitamins in primary endpoints.

Brand names
AquADEKs-2AquADEKs2AquADEKs 2
Other names
Antioxidant-enriched multivitamin supplementAquADEKs-2 multivitaminAquADEKs2 multivitaminAquADEKs 2 multivitamin
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on AquADEKs-2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AquADEKs-2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call